Opinion|Videos|November 17, 2026

Personalizing HIV Regimens: Patient Preferences, Bone, Lipids, and Comorbidities

Food requirements, bone and lipid risk, renal and hepatic function, and mental health each narrow the field, making regimen selection a genuinely individualized decision for every patient.

"Personalizing HIV Regimens: Patient Preferences, Bone, Lipids, and Comorbidities" takes up the question of how patient-specific factors translate into regimen choices.

Dr. Durham says regimen selection is highly patient specific. Most recommended oral regimens are one or two pills, so pill burden is less of a problem than with older therapy. However, first-line regimens cannot always be used, and alternatives may carry food requirements. Taking medication with food can be inconvenient for some schedules, while other patients struggle when it must be taken without food. He considers adverse-effect potential among the most important factors. Tenofovir disoproxil fumarate may be best avoided in patients at risk for osteoporosis. Tenofovir alafenamide may be less suitable for patients struggling with lipid management. Some patients fall into both categories, and a tenofovir-free regimen may be the best choice.

Dr. Madison adds that renal and bone health challenges often coexist. She emphasizes that food requirements, especially with rilpivirine-containing oral regimens, can undermine success. Taking these regimens without a sufficiently caloric meal can compromise virologic suppression.

Dr. Burkhart then reviews how comorbidities shape treatment conversations. For cardiovascular risk, older agents and some boosted regimens can worsen lipids. He notes recent guidance recommending statin therapy for people with HIV aged 40 to 75, even with low cholesterol. Many antiretrovirals are renally cleared, so declining kidney function may rule out certain tenofovir-containing regimens. Protease inhibitors are hepatically metabolized and require monitoring. Hepatitis B coinfection is critical, because removing HBV-active agents can trigger a flare. Mental health conditions such as depression, anxiety, and substance use disorder are common and often drive nonadherence. Wellness checks at each pharmacy touch point help.

Dr. Astle notes that some mental health medications are also long-acting injectables. Pharmacists should ask about other injections given at similar sites. Seeing prescriptions from multiple specialists lets pharmacists piece together the full picture and prompt reconnection with HIV care.

In "Optimizing HIV Adherence Through Team-Based Care and Diverse Treatment Options," the panel will share practical adherence strategies and explain why so many regimens are needed.

Funding supported by Gilead. Content independently developed by Pharmacy Times.


Related to this article